Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 393,500
-12,000 (-2.96%)
At close: Oct 29, 2025
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 4.99 trillion as of October 29, 2025. Its market cap has increased by 25.52% in one year.
Market Cap
4.99T
Enterprise Value
5.39T
Revenue
1.47T
Ranking
n/a
PE Ratio
46.48
Stock Price
393,500.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 4.99T, an increase of 633.02%. That is a compound annual growth rate of 13.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 4.99T | 40.29% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | 4.40T | 25.97% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 85.98T |
| Celltrion | 39.30T |
| ALTEOGEN | 25.86T |
| SK Biopharmaceuticals | 9.02T |
| Yuhan | 8.94T |
| Peptron | 6.37T |
| HLB Co., Ltd. | 6.06T |
| PharmaResearch | 5.55T |